TY - JOUR T1 - Response to: ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Yang <em>et al</em> JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis DO - 10.1136/annrheumdis-2021-219855 SP - annrheumdis-2021-219855 AU - Shintaro Akiyama AU - Shadi Hamdeh AU - Dejan Micic AU - Atsushi Sakuraba Y1 - 2021/01/14 UR - http://ard.bmj.com/content/early/2021/10/06/annrheumdis-2021-219855.abstract N2 - We thank Yang et al1 for their comments with an updated meta-analysis to our research article ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’.2 Their findings contribute to accurate elaboration and substantiation of our findings.Yang et al1 undertook an updated meta-analysis, including studies that were reported after our article was published, and found that patients with autoimmune diseases had a significantly increased risk of mortality compared with those without. This is in contrast to our results which showed no such increased risk. This difference is likely due to the larger number of publications and patients included in their updated meta-analysis. Indeed, there are a growing number of … ER -